FDA approves Shire's Vyvanse for binge-eating disorder

January 30, 2015 9:48 PM

22 0

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition.

Vyvanse, which is currently approved to treat attention deficit hyperactivity disorder, generated sales of more than $1 billion in the first nine months of last year.

Read more

To category page